Discover the precision and reliability of the Supreme Peptides Tirzepatide Peptide Vial, expertly formulated for advanced research applications. Each sterile vial is clearly labeled “Tirzepatide” and contains a premium synthetic peptide with purity exceeding 99%, ensuring consistency and reproducibility for laboratory professionals. Intended strictly for research use only, this high-grade peptide is designed for investigative studies focused on metabolic regulation, glucose homeostasis, and appetite signaling pathways. Packaged in a clear glass vial, it offers optimal stability, accuracy, and ease of handling in controlled research protocols.

Tirzepatide is a novel dual-agonist peptide studied for its ability to activate both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. In research settings, it has gained significant attention for its integrative role in regulating appetite, insulin signaling, and energy balance.

Product overview

Tirzepatide is a research-grade synthetic peptide engineered to simultaneously target incretin pathways involved in metabolic control. Preclinical and clinical research associate Tirzepatide with improved glucose utilization, appetite modulation, and enhanced metabolic efficiency. Its dual-receptor mechanism makes it a valuable tool for studying complex metabolic conditions and adaptive weight-management processes.

Key research features

Dual incretin receptor activation:
Tirzepatide is widely studied for its ability to activate both GLP-1 and GIP receptors, supporting research into synergistic effects on insulin signaling and metabolic regulation.

Appetite and weight-regulation research:
Studies suggest Tirzepatide may influence satiety signaling and caloric intake through central and peripheral pathways, making it relevant for experimental models focused on obesity and weight management.

Glucose metabolism and insulin sensitivity:
Research indicates Tirzepatide may improve glucose homeostasis and insulin response, supporting its use in studies examining metabolic health and energy balance.

Tirzepatide Suggested Use:

• Typical Dose: 2.5–15 mg per week

• Route: Subcutaneous injection

• Frequency: Once weekly

• Duration: As recommended by a healthcare professional

Note: Always consult a healthcare professional before use. Keep out of reach of children. All products are for research purposes and intended for human or animal consumption.